Metastatic Colorectal Cancers Withdrawn Phase 2 Trials for Atezolizumab (DB11595)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03340558Atezolizumab Monotherapy vs Atezolizumab Plus Cobimetinib in Liver Metastases From Colorectal CancerBasic Science